GlaxoSmithkline Consumer Healthcare has informed that a meeting of the Board of Directors of the company will be held on February 05, 2014 to consider and take on record the Unaudited Financial Results for the quarter ended on December 31, 2013 with Limited Review done by the Statutory Auditors (Q3).
The above information is a part of company’s filings submitted to BSE.